Prehospital Sepsis Protocol for Sepsis
(IMPRESS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method for emergency medical teams to quickly identify and respond to sepsis, a serious infection that can lead to organ failure, as soon as a patient arrives at the hospital. The trial aims to determine if a special protocol, called the PRESS Intervention, can expedite the initiation of crucial treatments. Participants are divided into two groups: one will use this new method, while the other will follow the usual care. Suitable candidates exhibit symptoms such as a high pulse or difficulty breathing and are being taken to a participating hospital. As an unphased trial, this study offers participants the chance to contribute to innovative approaches in emergency care.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this protocol is safe?
Research shows that the PRESS Intervention aims to identify and treat sepsis early, before patients reach the hospital. Studies have found that early detection and treatment of sepsis can improve patient outcomes. The intervention trains emergency medical services (EMS) to use early warning scores, tools designed to identify patients at high risk for sepsis.
Specific data on negative effects related to the PRESS Intervention is not available, but it focuses on improving the timing and delivery of care rather than introducing new drugs or treatments. This approach enhances current care practices, which generally makes it well-tolerated. The adoption of this protocol by the State of South Carolina's EMS indicates confidence in its safety and effectiveness.12345Why are researchers excited about this trial?
Researchers are excited about the PRESS Intervention for sepsis because it aims to optimize prehospital care, potentially improving outcomes before patients even reach the hospital. Unlike the standard approach, which typically begins intensive treatment upon hospital arrival, this intervention focuses on early recognition and management of sepsis symptoms by emergency medical services. By implementing this protocol in the field, the hope is to reduce delays in treatment, which can be crucial for improving survival rates and recovery in sepsis patients.
What evidence suggests that this protocol is effective for sepsis?
Research has shown that the PRESS Intervention, which participants in this trial may receive, helps emergency medical services (EMS) recognize sepsis earlier. One study found that a special EMS protocol improved the frequency of sepsis identification, enabling EMS teams to spot sepsis before patients reach the hospital. Early detection is crucial because it can lead to quicker treatment, potentially improving patient health. Another study found that starting treatment early, even before hospital arrival, might benefit patients in septic shock. Overall, these findings suggest that the PRESS Intervention could effectively recognize and manage sepsis early.13678
Who Is on the Research Team?
Carmen C Polito, MD, MSc
Principal Investigator
Emory University
Jonathan E Sevransky, MD, MHS
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for adults who have signs of sepsis, like a fast pulse rate over 90 bpm, low blood pressure under 110 mmHg, or rapid breathing over 20 breaths per minute. They must be transported by EMS to a participating hospital and meet other criteria such as being aged 40+, having a high temperature or low oxygen levels. Pregnant individuals and those with trauma, cardiac arrest, psychiatric emergencies or toxic ingestion are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Phase
Study sites participate in the standard of care phase to collect baseline data
Intervention Phase
Implementation of the PRESS protocol with sepsis screening and early warning protocol
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PRESS Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator